Neurological conditions affected 3.4 billion people globally in 2021: Lancet

Neurological conditions affected 3.4 billion people globally in 2021: Lancet

The most prevalent neurological disorders in 2021 were tension-type headaches (around 2 billion cases) and migraines (about 1.1 billion cases). Diabetic neuropathy is the fastest-growing of all neurological conditions, the researchers said. “The number of people with diabetic neuropathy has more than tripled globally since 1990, rising to 206 million in 2021,” said study co-senior …

Read more

Digital Therapeutics Revolutionizing Women’s Cardiac Health, Health News, ET HealthWorld

Digital Therapeutics Revolutionizing Women’s Cardiac Health, Health News, ET HealthWorld

Every year, we celebrate International Women’s Day, honoring the achievements and contributions of women worldwide. Yet amidst the festivities, an often overlooked aspect is the silent danger lurking for women: their heart health. Despite advancements in various fields, women’s cardiac health remains a pressing concern, overshadowed by other health issues. According to a report by …

Read more

From undernutrition to obesity, Lancet study unveils India’s double whammy

From undernutrition to obesity, Lancet study unveils India’s double whammy

New Delhi, India is grappling with a profound nutritional shift, as highlighted by the latest Lancet study, with nutritionists attributing this “double whammy” of undernutrition and obesity to a dual challenge: inadequate consumption of quality foods and easy access to cheap, unhealthy alternatives. The Lancet study, published on Thursday, found that in India, nearly 44 …

Read more

India’s cervical cancer drug, Cervavac, as efficient as global medicines: Lancet

India’s cervical cancer drug, Cervavac, as efficient as global medicines: Lancet

NEW DELHI :India’s first indigenously developed vaccine for the prevention of cervical cancer has the same efficacy as those procured from other countries, according to a recent study published in the medical journal Lancet. Serum Institute of India developed the vaccine, called Cervavac, to be administered to youngsters between ages 9 and 26. The vaccine, …

Read more